» Articles » PMID: 31935372

Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis

Abstract

Metastasis is the primary cause of death of cancer patients. Dissecting mechanisms governing metastatic spread may uncover important tumor biology and/or yield promising therapeutic insights. Here, we investigated the role of circular RNAs (circRNA) in metastasis, using melanoma as a model aggressive tumor. We identified silencing of cerebellar degeneration-related 1 antisense (CDR1as), a regulator of miR-7, as a hallmark of melanoma progression. CDR1as depletion results from epigenetic silencing of LINC00632, its originating long non-coding RNA (lncRNA) and promotes invasion in vitro and metastasis in vivo through a miR-7-independent, IGF2BP3-mediated mechanism. Moreover, CDR1as levels reflect cellular states associated with distinct therapeutic responses. Our study reveals functional, prognostic, and predictive roles for CDR1as and expose circRNAs as key players in metastasis.

Citing Articles

The prognosis of ciRS-7 and circHIPK3 in pan-cancer: a mini-review and meta-analysis.

Li X, Wu T, Dong R, Wu X Discov Oncol. 2025; 16(1):207.

PMID: 39969753 PMC: 11839969. DOI: 10.1007/s12672-025-01944-2.


Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.

Hatzimanolis O, Sykes A, Cristino A Mol Psychiatry. 2025; .

PMID: 39966624 DOI: 10.1038/s41380-025-02925-1.


Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs.

Lv Q, Wang G, Hong Y, Zhu T, Qin S, Sun S Oncol Res. 2025; 33(2):407-420.

PMID: 39866227 PMC: 11754003. DOI: 10.32604/or.2024.047698.


hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression.

Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y J Exp Clin Cancer Res. 2025; 44(1):8.

PMID: 39773744 PMC: 11705778. DOI: 10.1186/s13046-024-03264-9.


The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma.

Schaft N, Dorrie J Methods Mol Biol. 2024; 2883:79-107.

PMID: 39702705 DOI: 10.1007/978-1-0716-4290-0_4.


References
1.
Hu B, Yang Y, Huang Y, Zhu Y, Lu Z . POSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Res. 2017; 45(D1):D104-D114. PMC: 5210617. DOI: 10.1093/nar/gkw888. View

2.
Konieczkowski D, Johannessen C, Abudayyeh O, Kim J, Cooper Z, Piris A . A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 2014; 4(7):816-27. PMC: 4154497. DOI: 10.1158/2159-8290.CD-13-0424. View

3.
Schneider T, Hung L, Schreiner S, Starke S, Eckhof H, Rossbach O . CircRNA-protein complexes: IMP3 protein component defines subfamily of circRNPs. Sci Rep. 2016; 6:31313. PMC: 4980667. DOI: 10.1038/srep31313. View

4.
Yang W, Sriramaratnam R, Welsch M, Shimada K, Skouta R, Viswanathan V . Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1-2):317-331. PMC: 4076414. DOI: 10.1016/j.cell.2013.12.010. View

5.
Jonson L, Christiansen J, Hansen T, Vikesa J, Yamamoto Y, Nielsen F . IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development. Cell Rep. 2014; 7(2):539-551. DOI: 10.1016/j.celrep.2014.03.015. View